TO THE Purchase Manager Pharmaceutical Import Profile — Ecuador (DGFT 2022–2026)

Name: TO THE Purchase Manager Pharmaceutical Import Records from India — 3 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

TO THE Purchase Manager — Pharmaceutical Importer Profile (2026) | 3 Products, $1.3M Trade | TransData Nexus

TO THE Purchase Manager

Pharmaceutical Importer · Ecuador · Cardiovascular Focus · $1.3M Total Trade · DGFT Verified

TO THE Purchase Manager is a pharmaceutical importer based in Ecuador with a total trade value of $1.3M across 3 products in 2 therapeutic categories. Based on 26 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. TO THE Purchase Manager sources from 10 verified Indian suppliers, with Caritas Healthcare Private Limited accounting for 90.6% of imports.

TO THE Purchase Manager — Import Portfolio & Supplier Network

TO THE Purchase Manager import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to TO THE Purchase Manager?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caritas Healthcare Private Limited	$2.7M	129	90.6%
Mericana Pharmaceuticals Private Limited	$100.6K	3	3.4%
Regalia Life Science Private Limited	$60.9K	202

What Formulations Does TO THE Purchase Manager Import?

Formulation	Value	Ships
Methylprednisolone sodium succinate	$202.1K	6
Carvedilol tablets 12.5MG batch	$150.0K	3
Urea cream 10% w/w batch no.22103	$131.0K	3
Rivaroxaban 10 MG batch no.emv221507	$115.6K	3
Sildenafil citrate tablets 100 MG	$114.8K	3
Metformin tablets BP 1000 MG batch	$114.0K	3
Finished pharmaceutical product -	$76.3K	3
Hydroxychloroquine film coated tablets	$70.8K	3
Finished pharmaceutical product - urea	$67.4K	2
Amoxicillin oral suspension BP 100 MG/ML	$60.8K	2
Atorvastatin tablets 40 MG	$57.1K	3
Dicloxacillin sod. for oral suspension	$50.0K	1
Zinc oxide ointment 30GM batch	$50.0K	1
Hydrocortisone sodium succinate for	$50.0K	1
Fluorouracil cream 30GM batch no.e2254	$50.0K	1

TO THE Purchase Manager imports 249 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Carvedilol	Cardiovascular	$500.0K	10	0.5%	2
2	Rivaroxaban	Cardiovascular	$450.0K	9	0.9%	3
3	Methylprednisolone	Corticosteroids	$350.0K	7	1.2%	11

TO THE Purchase Manager imports 3 pharmaceutical products across 2 categories into Ecuador totaling $1.3M.

TO THE Purchase Manager — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

TO THE Purchase Manager is a pharmaceutical importer and buyer based in Ecuador, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. The company plays a pivotal role in the Ecuadorian pharmaceutical distribution network, ensuring the availability of essential medications across the country. With a total import value of $1.3 million USD from India over 26 shipments, TO THE Purchase Manager demonstrates a significant commitment to sourcing quality pharmaceutical products. The company's portfolio encompasses three primary products across two therapeutic categories, underscoring its focus on specific medical needs.

2Distribution Network

While specific details about TO THE Purchase Manager's warehouse locations and logistics capabilities are not publicly disclosed, the company's substantial import activities suggest a well-established distribution network within Ecuador. The strategic sourcing of products from India indicates a reliance on efficient international shipping routes and partnerships with logistics providers to ensure timely delivery and distribution of pharmaceutical products throughout the country.

3Industry Role

TO THE Purchase Manager functions as a pharmaceutical importer and buyer, acting as an intermediary between international suppliers and the Ecuadorian market. By sourcing finished pharmaceutical formulations from India, the company ensures the availability of essential medications, thereby playing a crucial role in the pharmaceutical supply chain within Ecuador.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — TO THE Purchase Manager

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of the import value. This indicates a focused approach to procurement, potentially streamlining operations and fostering strong relationships with key suppliers. However, such concentration may also pose risks, including supply chain disruptions if any of these suppliers face operational challenges. The shipment data reveals a consistent pattern of imports, suggesting a stable and ongoing relationship with these suppliers.

2Supply Chain Resilience

TO THE Purchase Manager's supply chain resilience appears robust, given the consistent importation of finished pharmaceutical formulations from a select group of Indian suppliers. The diversity of formulations imported indicates a strategic approach to meeting various therapeutic needs. However, the reliance on a limited number of suppliers may expose the company to risks associated with supply chain disruptions. Ensuring compliance with international standards and maintaining strong relationships with these suppliers are essential for mitigating potential risks.

3Strategic Implications

Importing Pharmaceuticals into Ecuador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ecuador

1Regulatory Authority & Framework

In Ecuador, the National Agency for Regulation, Control, and Sanitary Surveillance (ARCSA) is the primary regulatory body overseeing the pharmaceutical sector. ARCSA is responsible for the registration, control, and surveillance of pharmaceutical products, ensuring they meet safety, efficacy, and quality standards. Key legislation governing pharmaceutical imports includes the Health Code and specific regulations pertaining to Good Manufacturing Practices (GMP). The marketing authorization pathway for Indian generics involves obtaining a sanitary registration certificate from ARCSA, which requires compliance with ARCSA's technical regulations and submission of necessary documentation.

2Import Licensing & GMP

Importers in Ecuador must register with the Ecuadorian Customs Service (SENAE) and obtain a company tax number (RUC) issued by the Ecuadorian Internal Revenue Service (SRI). Pharmaceutical products must be approved by ARCSA, which involves submitting a dossier that includes GMP verification, labeling compliance in Spanish, stability and shelf-life data, and the appointment of a local sanitary representative. For controlled substances, special import permits are required from ARCSA and the National Council for the Control of Narcotic and Psychotropic Substances (CONSEP). Importers must also comply with labeling requirements, including the use of the Unique Traceability Code (CUT) as mandated by ARCSA.

TO THE Purchase Manager — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

TO THE Purchase Manager's focus on cardiovascular medications, particularly Carvedilol and Rivaroxaban, and corticosteroids like Methylprednisolone, indicates a strategic alignment with prevalent health concerns in Ecuador. The significant import values of these products suggest a strong market demand and the company's commitment to addressing critical therapeutic needs. This targeted product strategy positions TO THE Purchase Manager as a key supplier of essential medications in the Ecuadorian market.

2Sourcing Profile

TO THE Purchase Manager's sourcing strategy is centered on acquiring finished pharmaceutical formulations from Indian manufacturers, emphasizing quality and reliability. The company's portfolio includes a diverse range of formulations, indicating a comprehensive approach to meeting various therapeutic needs. This strategy leverages India's established pharmaceutical manufacturing capabilities and aligns with Ecuador's regulatory requirements for imported medicines.

3Market Positioning

Based on its product mix, TO THE Purchase Manager serves a broad segment of the Ecuadorian pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's focus on essential medications positions it as a critical supplier in the healthcare sector, contributing to the availability of necessary treatments across the country.

Seller's Guide — How to Become a Supplier to TO THE Purchase Manager

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with TO THE Purchase Manager, especially those offering high-quality finished pharmaceutical formulations that meet ARCSA's regulatory standards. Gaps in the current sourcing strategy may include the need for additional suppliers to diversify the product range and enhance supply chain resilience. Establishing partnerships with TO THE Purchase Manager could provide Indian exporters with access to the Ecuadorian market and contribute to the company's goal of addressing diverse therapeutic needs.

2Requirements & Qualifications

Indian exporters seeking to supply TO THE Purchase Manager and the Ecuadorian market must ensure compliance with ARCSA's regulatory requirements, including obtaining a sanitary registration certificate for each product. Products must adhere to ARCSA's labeling standards, including the use of the Unique Traceability Code (CUT) in Spanish. Additionally, exporters should ensure that their manufacturing facilities comply with Good Manufacturing Practices (GMP) as recognized by ARCSA.

3How to Approach

Frequently Asked Questions — TO THE Purchase Manager

What products does TO THE Purchase Manager import from India?

TO THE Purchase Manager imports 3 pharmaceutical products across 2 categories. Top imports: Carvedilol ($500.0K), Rivaroxaban ($450.0K), Methylprednisolone ($350.0K).

Who supplies pharmaceuticals to TO THE Purchase Manager from India?

TO THE Purchase Manager sources from 10 verified Indian suppliers. The primary supplier is Caritas Healthcare Private Limited (90.6% of imports, $2.7M).

What is TO THE Purchase Manager's total pharmaceutical import value?

TO THE Purchase Manager's total pharmaceutical import value from India is $1.3M, based on 26 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does TO THE Purchase Manager focus on?

TO THE Purchase Manager imports across 2 categories. The largest: Cardiovascular (73.1%), Corticosteroids (26.9%).

Get Full TO THE Purchase Manager Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.